ResearcherUniversity of MinnesotaActive in the last 2 years

Pegah Farrokhi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5410-0443; OpenAlex author ID A5005967255. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019-2024. Co-author DOI 10.3389/fonc.2026.1844261 ↗
Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer. Co-author DOI 10.22088/cjim.12.0.407 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

David Dean Stenehjem · 1 shared paper, 2026 · strength 0.32
- Paper Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United Stat… DOI 10.3389/fonc.2026.1844261 ↗
Rupali M Fuldeore · 1 shared paper, 2026 · strength 0.32
- Paper Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United Stat… DOI 10.3389/fonc.2026.1844261 ↗
Saman Dinari · 1 shared paper, 2021 · strength 0.17
- Paper Primary Squamous Cell Carcinoma, a Rare Pathological Report of Pancreatic Cancer. DOI 10.22088/cjim.12.0.407 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.